These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

299 related articles for article (PubMed ID: 31777870)

  • 1. Tirapazamine-embedded polyplatinum(iv) complex: a prodrug combo for hypoxia-activated synergistic chemotherapy.
    Guo D; Xu S; Yasen W; Zhang C; Shen J; Huang Y; Chen D; Zhu X
    Biomater Sci; 2020 Jan; 8(2):694-701. PubMed ID: 31777870
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Platinum(IV) complex-based two-in-one polyprodrug for a combinatorial chemo-photodynamic therapy.
    Guo D; Xu S; Huang Y; Jiang H; Yasen W; Wang N; Su Y; Qian J; Li J; Zhang C; Zhu X
    Biomaterials; 2018 Sep; 177():67-77. PubMed ID: 29885587
    [TBL] [Abstract][Full Text] [Related]  

  • 3. ROS-sensitive biomimetic nanocarriers modulate tumor hypoxia for synergistic photodynamic chemotherapy.
    Liu H; Jiang W; Wang Q; Hang L; Wang Y; Wang Y
    Biomater Sci; 2019 Aug; 7(9):3706-3716. PubMed ID: 31187794
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Targeting triple-negative breast cancer with an aptamer-functionalized nanoformulation: a synergistic treatment that combines photodynamic and bioreductive therapies.
    Chou YT; Lin CY; Wen JW; Hung LC; Chang YF; Yang CM; Wu LC; Ho JA
    J Nanobiotechnology; 2021 Mar; 19(1):89. PubMed ID: 33781277
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Anti-LDLR modified TPZ@Ce6-PEG complexes for tumor hypoxia-targeting chemo-/radio-/photodynamic/photothermal therapy.
    Song C; Xu W; Wei Z; Ou C; Wu J; Tong J; Cai Y; Dong X; Han W
    J Mater Chem B; 2020 Jan; 8(4):648-654. PubMed ID: 31898718
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Developing Hypoxia-Sensitive System via Designing Tumor-Targeted Fullerene-Based Photosensitizer for Multimodal Therapy of Deep Tumor.
    Li L; Fu J; Ye J; Liu L; Sun Z; Wang H; Tan S; Zhen M; Wang C; Bai C
    Adv Mater; 2024 Jun; 36(23):e2310875. PubMed ID: 38450765
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-Penetrating Nanoparticles for Enhanced Anticancer Activity of Combined Photodynamic and Hypoxia-Activated Therapy.
    Wang Y; Xie Y; Li J; Peng ZH; Sheinin Y; Zhou J; Oupický D
    ACS Nano; 2017 Feb; 11(2):2227-2238. PubMed ID: 28165223
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sorafenib-Encapsulated Liposomes to Activate Hypoxia-Sensitive Tirapazamine for Synergistic Chemotherapy of Hepatocellular Carcinoma.
    Zhao J; Dai W; Zhan L; Lei L; Jin Q; Wang J; Tang Z
    ACS Appl Mater Interfaces; 2024 Mar; 16(9):11289-11304. PubMed ID: 38393963
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Erythrocyte Membrane Cloaked Metal-Organic Framework Nanoparticle as Biomimetic Nanoreactor for Starvation-Activated Colon Cancer Therapy.
    Zhang L; Wang Z; Zhang Y; Cao F; Dong K; Ren J; Qu X
    ACS Nano; 2018 Oct; 12(10):10201-10211. PubMed ID: 30265804
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Organosilica-Based Hollow Mesoporous Bilirubin Nanoparticles for Antioxidation-Activated Self-Protection and Tumor-Specific Deoxygenation-Driven Synergistic Therapy.
    Shan L; Fan W; Wang W; Tang W; Yang Z; Wang Z; Liu Y; Shen Z; Dai Y; Cheng S; Jacobson O; Zhai K; Hu J; Ma Y; Kiesewetter DO; Gao G; Chen X
    ACS Nano; 2019 Aug; 13(8):8903-8916. PubMed ID: 31374171
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Iodinated cyanine dye-based nanosystem for synergistic phototherapy and hypoxia-activated bioreductive therapy.
    Dong Y; Zhou L; Shen Z; Ma Q; Zhao Y; Sun Y; Cao J
    Drug Deliv; 2022 Dec; 29(1):238-253. PubMed ID: 35001784
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Multifunctional Theranostic Liposomes Loaded with a Hypoxia-Activated Prodrug for Cascade-Activated Tumor Selective Combination Therapy.
    Dai Y; Wang B; Sun Z; Cheng J; Zhao H; Wu K; Sun P; Shen Q; Li M; Fan Q
    ACS Appl Mater Interfaces; 2019 Oct; 11(43):39410-39423. PubMed ID: 31578854
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Subcellular Location of Tirapazamine Reduction Dramatically Affects Aerobic but Not Anoxic Cytotoxicity.
    Guise CP; Abbattista MR; Anderson RF; Li D; Taghipouran R; Tsai A; Lee SJ; Smaill JB; Denny WA; Hay MP; Wilson WR; Hicks KO; Patterson AV
    Molecules; 2020 Oct; 25(21):. PubMed ID: 33105798
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Near-infrared light triggered liposomes combining photodynamic and chemotherapy for synergistic breast tumor therapy.
    Yang Y; Yang X; Li H; Li C; Ding H; Zhang M; Guo Y; Sun M
    Colloids Surf B Biointerfaces; 2019 Jan; 173():564-570. PubMed ID: 30347383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. H
    Qiao L; Ou Y; Li L; Wu S; Guo Y; Liu M; Yu D; Chen Q; Yuan J; Wei C; Ou C; Li H; Cheng D; Yu Z; Li Z
    J Nanobiotechnology; 2024 Apr; 22(1):205. PubMed ID: 38658965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. An efficient delivery of photosensitizers and hypoxic prodrugs for a tumor combination therapy by membrane camouflage nanoparticles.
    Wang H; Zhang C; Zhang Y; Tian R; Cheng G; Pan H; Cui M; Chang J
    J Mater Chem B; 2020 Apr; 8(14):2876-2886. PubMed ID: 32191252
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combination of the bioreductive drug tirapazamine with the chemotherapeutic prodrug cyclophosphamide for P450/P450-reductase-based cancer gene therapy.
    Jounaidi Y; Waxman DJ
    Cancer Res; 2000 Jul; 60(14):3761-9. PubMed ID: 10919648
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Spatiotemporal Concurrent Liberation of Cytotoxins from Dual-Prodrug Nanomedicine for Synergistic Antitumor Therapy.
    Zhang L; Qian M; Cui H; Zeng S; Wang J; Chen Q
    ACS Appl Mater Interfaces; 2021 Feb; 13(5):6053-6068. PubMed ID: 33525873
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Glutathione-Responsive Polymersome with Continuous Glutathione Depletion for Enhanced Photodynamic Therapy and Hypoxia-Activated Chemotherapy.
    Cheng G; Tao S; Liu S; Wang P; Zhang C; Liu J; Hao C; Wang S; Guo D; Xu B
    ACS Macro Lett; 2024 May; 13(5):599-606. PubMed ID: 38683197
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyaluronan-fullerene/AIEgen nanogel as CD44-targeted delivery of tirapazamine for synergistic photodynamic-hypoxia activated therapy.
    Hong X; Xu X; Liu Z; Liu S; Yu J; Wu M; Ma Y; Shuai Q
    Nanotechnology; 2021 Aug; 32(46):. PubMed ID: 34325415
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.